June 8, 2020 / 4:07 PM / a month ago

Grifols CFO expects drop in plasma donations to be short-lived

MADRID, June 8 (Reuters) - Spanish pharmaceuticals company Grifols expects to recover quickly from a drop in plasma donations that forced it to book a 200 million euro ($226 million) hit in its first-quarter earnings, its chief financial officer said on Monday.

A drop in donations because of the COVID-19 crisis has driven up the cost of obtaining plasma, weighing on profitability.

“Despite this decline, we are already witnessing a fast recovery in plasma collections and we expect to return to pre-COVID-19 volumes shortly,” said CFO Alfredo Arroyo. ($1 = 0.8853 euros) (Reporting by Nathan Allen Editing by David Goodman )

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below